Literature DB >> 22429349

A primary proteomic analysis of serum from patients with nonfunctioning pituitary adenoma.

X Hu1, P Zhang, A Shang, Q Li, Y Xia, G Jia, W Liu, X Xiao, D He.   

Abstract

OBJECTIVE: The early diagnosis of nonfunctioning pituitary adenoma (NFPA) is difficult. The objective of this study was to find specific protein biomarkers to aid in the early detection of NFPA.
METHODS: Serum samples from 34 patients with NFPA and 34 age- and sex-matched healthy control subjects were analysed using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology. The spectra were generated, protein peak clustering was performed and classification analyses were carried out using a decision tree classification algorithm.
RESULTS: Nine differentially expressed serum proteins were identified in the patients with NFPA compared with the control subjects. Both the sensitivity and specificity of the decision tree classification algorithm were 82.4% for NFPA.
CONCLUSIONS: Nine new serum protein biomarkers for NFPA were identified. SELDI-TOF-MS coupled with data mining tools might provide a novel approach for the early diagnosis of NFPA and population screening for the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429349     DOI: 10.1177/147323001204000110

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

1.  Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Xiaowei Wang; Ying Long; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2014-12-24       Impact factor: 3.063

Review 2.  Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Tingting Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-31       Impact factor: 5.555

3.  A systematic review on machine learning in sellar region diseases: quality and reporting items.

Authors:  Nidan Qiao
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

Review 4.  BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

Authors:  Thomas J van Ee; Heleen H Van Acker; Tom G van Oorschot; Viggo F Van Tendeloo; Evelien L Smits; Ghaith Bakdash; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Vaccines (Basel)       Date:  2018-09-19

5.  Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients.

Authors:  Tingting Cheng; Ya Wang; Miaolong Lu; Xiaohan Zhan; Tian Zhou; Biao Li; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-05       Impact factor: 5.555

6.  TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.

Authors:  Ya Wang; Tingting Cheng; Miaolong Lu; Yun Mu; Biao Li; Xuejun Li; Xianquan Zhan
Journal:  EPMA J       Date:  2019-08-29       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.